Bellus Health Company
BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys.
Technology:
Cancer
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Total Funding:
$44.6M
Estimated Revenue:
$1M to $10M
Industry:
PharmTech
Acquisitions Number:
2
Headquarters:
Canada
Employee Number:
11-50
Founded Date:
2010